CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea

Gastro Hep Advances · Elsevier

Аннотация

Publication date: 2026 Source: Gastro Hep Advances, Volume 5, Issue 12 Author(s): Kyle Staller, Jenna Clukey, Elizabeth N. Madva, Brian C. Healy, Minyi Lee, Manish K. Gala

Читать у издателя →

Похожие статьи